KPT–9274 is recognized as a dual inhibitor of PAK4 and NAMPT, which is capable of effectively inhibiting the growth of mantle cell lymphoma, follicular lymphoma, and diffuse large B-cell lymphoma [103]. Here, PAK4 is linked to follicular lymphoma.